Despite the immune system being triggered by the vaccinations, the main group of antibodies in each person’s blood remained exactly the same in type, amount, and structure. Our immune system relies on ...

FDA introduces a new roadmap to reduce animal testing in monoclonal antibody development using AI models, organoid testing and real-world data to enhance safety and efficiency.

In the landmark Amgen v. Sanofi case (previously covered here), the Supreme Court affirmed that patent claims drawn to a genus of ...

Current written description jurisprudence can make it difficult to obtain broad antibody patents, leading practitioners to explore ...

High-speed atomic force m (HS-AFM) reveals nanoscale differences in small extracellular vesicles (sEVs), improving biomarker ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

NBE Therapeutics focuses on developing next-generation ADCs, a targeted approach that delivers cancer-fighting agents directly to tumor cells while limiting effects on healthy tissue. ADCs combine the ...

ImmunoPrecise Antibodies Ltd. (NASDAQ ... while strengthening our capital structure, enhancing investor clarity and positioning us to scale growth initiatives from a clean financial foundation.

Antibody molecules, or “immunoglobulins”, have been recognized only in vertebrates and all are found to have a fundamentally similar structure consisting of two heavy and two light peptide chains.

Because immunoglobulins are matched to a specific pathogen, they can be used to diagnose some diseases based on their unique structure. Antibody tests are used to detect disease-specific antibodies in ...

ImmunoPrecise Antibodies Ltd. (IPA) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.08 per share a year ago. These figures ...

Attribution (BY): Credit must be given to the creator. Immunoreagents, most commonly antibodies, are integral components of lateral flow immunoassays. However, the use of antibodies comes with ...